About Histogen

Histogen is a regenerative medicine company focused on developing patented, innovative technologies for aesthetic and therapeutic markets based on stimulating the body’s stem cells to regenerate tissues and restore youthful function. The Company’s lead therapeutic product has demonstrated in clinical studies to stimulate hair growth, addressing an underserved, multibillion dollar global market. Further applications of the technology include skincare, orthopedics indications such as cartilage formation and spinal disk repair, wound healing and dermal fillers.


Histogen, Inc., a Delaware Corporation, was founded in 2007 to develop innovative products utilizing the proteins and growth factors produced by cells grown under simulated embryonic conditions. The Company is headquartered in San Diego, California.

Histogen founder Dr. Gail Naughton is a highly respected scientist with extensive experience in the field of tissue engineering and regenerative medicine. Dr. Naughton discovered the potential of proteins and growth factors produced by hypoxia-induced multipotent cells for therapeutic and biomedical applications, and developed Histogen’s unique technology process to create products based on these proteins. The technology is protected by patent families filed in the US and across key geographies.


Our Mission

To redefine regenerative medicine by developing high value therapeutic and aesthetic products that stimulate the body’s own stem cells to regenerate tissues, without the use of embryonic stem cells or animal components.


Histogen’s Executive Management team has decades of experience in bringing cell-based regenerative products from concept to market. In addition, the Company’s Board of Directors and Scientific Advisors are leaders in the fields of regenerative medicine and global marketing and business operations. Histogen has brought on experienced consultants to advise the team in regulatory, quality and production areas. In 2017, Histogen’s Board of Directors created an Office of the CEO (OTC), a group of executives to lead the Company through its next stages of success. The Office of the CEO consists of Chairman of the Board Dr. Stephen Chang, Dr. Martin Latterich and Mr. Thomas Hubka.

Board of Directors

Latest News

Recent & Upcoming Events

February 6-7, 2018

2018 San Diego Health Impact Forum

San Diego, CA
Dr. Gail Naughton to present.
February 28 - March 1, 2018

Biocom Global Life Science Conference

La Jolla, CA
Dr. Gail Naughton to present
March 26-28, 2018


Miami, FL
Dr. Gail Naughton to present "Induction of hair growth and tissue regeneration by hypoxia induced stem cell secreted proteins."
April 12-13, 2018

Stem Cell Summit

Boston, MA
Dr. Gail Naughton to participate in panel discussion "Funding & Commercialization of Cell Therapy"
April 17, 2018

ARM Cell & Gene Investor Day

New York, NY
Dr. Stephen Chang to present.
May 14-15, 2018

Skin Care Conference & Expo

Montreal, Canada
Dr. Gail Naughton to present "Naturally Secreted Growth Factors for Aesthetics: Stimulating Skin and Hair Follicle Stem Cells"
May 14-16

American Hair Research Summit (AHRS) 2018

Orlando, FL
Histogen to present "Hair Follicle Stem Cell Stimulation By Naturally Secreted Growth Factors Induces New Hair Growth In Men And Women"
October 10-12, 2018

BioNetwork Partnering Summit

Laguna Niguel, CA
Dr. Gail Naughton to present.
October 17-18, 2018

BIO Investor Forum

San Francisco, CA
Dr. Gail Naughton to present.


No current openings